BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 18630678)

  • 1. [Effect of HSP90 function inhibited on the telomerase and P53 mutant in breast cancer cells].
    Li X; Deng HY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):181-3. PubMed ID: 18630678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
    Schwock J; Pham NA; Cao MP; Hedley DW
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geldanamycin and its analog induce cytotoxicity in cultured human retinal pigment epithelial cells.
    Wu WC; Wu MH; Chang YC; Hsieh MC; Wu HJ; Cheng KC; Lai YH; Kao YH
    Exp Eye Res; 2010 Aug; 91(2):211-9. PubMed ID: 20493187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 independent radio-sensitization of human lymphoblastoid cell lines by Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin.
    Fujii Y; Kato T; Kubota N; Fujimori A; Niwa O; Okayasu R
    Oncol Rep; 2010 Jan; 23(1):199-203. PubMed ID: 19956882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of wild-type and mutant E-cadherin on cell proliferation and responsiveness to the chemotherapeutic agents cisplatin, etoposide, and 5-fluorouracil.
    Fricke E; Hermannstädter C; Keller G; Fuchs M; Brunner I; Busch R; Höfler H; Becker KF; Luber B
    Oncology; 2004; 66(2):150-9. PubMed ID: 15138368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of triptolide from Tripterygium wilfordii on ERalpha and p53 expression in two human breast cancer cell lines.
    Liu J; Jiang Z; Xiao J; Zhang Y; Lin S; Duan W; Yao J; Liu C; Huang X; Wang T; Liang Z; Wang R; Zhang S; Zhang L
    Phytomedicine; 2009 Nov; 16(11):1006-13. PubMed ID: 19524422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells.
    Leng AM; Liu T; Yang J; Cui JF; Li XH; Zhu YN; Xiong T; Zhang G; Chen Y
    Cell Biol Int; 2012 Oct; 36(10):893-9. PubMed ID: 22694478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The heat shock protein 90 inhibitor induces apoptosis and differentiation of Kasumi-1 and its mechanisms].
    Yu WJ; Rao Q; Wang M; Tian Z; Liu XR; Lin D; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):728-31. PubMed ID: 16620576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteome-wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells.
    Schumacher JA; Crockett DK; Elenitoba-Johnson KS; Lim MS
    Proteomics; 2007 Aug; 7(15):2603-16. PubMed ID: 17610208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Geldanamycin inhibits proliferation and motility of human HER2/neu-overexpressing breast cancer cell line SKBr3].
    Wang K; Ma QY; Ren Y; He JJ; Chen WK
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1480-4. PubMed ID: 17959518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging role of p53, bcl-2 and telomerase activity in Egyptian breast cancer patients.
    Swellam M; Ismail M; Eissa S; Hamdy M; Mokhtar N
    IUBMB Life; 2004 Aug; 56(8):483-90. PubMed ID: 15545228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hsp90 inhibitor 17-allylamide-17-demethoxygeldanamycin induces apoptosis and differentiation of Kasumi-1 harboring the Asn822Lys KIT mutation and down-regulates KIT protein level.
    Yu W; Rao Q; Wang M; Tian Z; Lin D; Liu X; Wang J
    Leuk Res; 2006 May; 30(5):575-82. PubMed ID: 16213582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geldanamycin prevents nuclear translocation of mutant p53.
    Dasgupta G; Momand J
    Exp Cell Res; 1997 Nov; 237(1):29-37. PubMed ID: 9417863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSP90 antagonist, geldanamycin, inhibits proliferation, induces apoptosis and blocks migration of rhabdomyosarcoma cells in vitro and seeding into bone marrow in vivo.
    Lesko E; Gozdzik J; Kijowski J; Jenner B; Wiecha O; Majka M
    Anticancer Drugs; 2007 Nov; 18(10):1173-81. PubMed ID: 17893518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the hsp90 inhibitor geldanamycin on androgen response of prostate cancer under hypoxic conditions.
    Suzuki Y; Kondo Y; Hara S; Kimata R; Nishimura T
    Int J Urol; 2010 Mar; 17(3):281-5. PubMed ID: 20409220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geldanamycin, a HSP90 inhibitor, attenuates the hypoxia-induced vascular endothelial growth factor expression in retinal pigment epithelium cells in vitro.
    Wu WC; Kao YH; Hu PS; Chen JH
    Exp Eye Res; 2007 Nov; 85(5):721-31. PubMed ID: 17870069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468.
    Avila MA; Velasco JA; Cansado J; Notario V
    Cancer Res; 1994 May; 54(9):2424-8. PubMed ID: 8162591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells.
    Massey AJ; Williamson DS; Browne H; Murray JB; Dokurno P; Shaw T; Macias AT; Daniels Z; Geoffroy S; Dopson M; Lavan P; Matassova N; Francis GL; Graham CJ; Parsons R; Wang Y; Padfield A; Comer M; Drysdale MJ; Wood M
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):535-45. PubMed ID: 20012863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells.
    Farina AR; Tacconelli A; Cappabianca L; Cea G; Chioda A; Romanelli A; Pensato S; Pedone C; Gulino A; Mackay AR
    Oncogene; 2009 Nov; 28(46):4075-94. PubMed ID: 19734938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitory and apoptosis regulating effects of adriamycin on different human breast cancer cell lines].
    Yu ZY; Zuo WS; Wei L; Shan PY; Song XR; Liu YT; Liu YS; Zhou ZB; Shao ZM
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):19-22. PubMed ID: 15808069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.